Literature DB >> 11837991

The oxidant stress hypothesis of atherogenesis.

L Iuliano1.   

Abstract

Atherosclerosis is the commonest lesion of blood vessels and is responsible for life-threatening events such as myocardial infarction and stroke. In the last two decades a series of excellent studies unraveled biochemical mechanisms that provided the background for a theory of atherogenesis. This theory is centered on foam cells and on free radical-mediated modification of low density lipoprotein (LDL). Foam cells are the main cell type of atherosclerotic lesions and originate from monocytes migrated from blood and from smooth muscle cells of the arterial wall. Foam cells are engulfed of lipids taken from LDL. Paradoxically, accumulation of LDL in developing foam cells does not occur via the classic LDL receptor. Incubation of macrophages with even very high concentrations of LDL does not appreciably increase cholesterol content. Chemically modified LDL easily enter the cells of atherosclerotic plaque via an unregulated receptor, the scavenger receptor. The most studied chemical modification of LDL is that induced by free radicals.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11837991     DOI: 10.1007/s11745-001-0680-1

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  33 in total

Review 1.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

2.  Studies on the role of lipoperoxides in human pathology. II. The presence of peroxidized lipids in the atherosclerotic aorta.

Authors:  J GLAVIND; S HARTMANN; J CLEMMESEN; K E JESSEN; H DAM
Journal:  Acta Pathol Microbiol Scand       Date:  1952

Review 3.  Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis.

Authors:  D Steinberg
Journal:  Circulation       Date:  1997-02-18       Impact factor: 29.690

4.  Preparation and biodistribution of 99m technetium labelled oxidized LDL in man.

Authors:  L Iuliano; A Signore; S Vallabajosula; A R Colavita; C Camastra; G Ronga; C Alessandri; E Sbarigia; P Fiorani; F Violi
Journal:  Atherosclerosis       Date:  1996-09-27       Impact factor: 5.162

5.  Protection of low density lipoprotein oxidation at chemical and cellular level by the antioxidant drug dipyridamole.

Authors:  L Iuliano; A R Colavita; C Camastra; V Bello; C Quintarelli; M Alessandroni; F Piovella; F Violi
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

6.  Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins.

Authors:  T Henriksen; E M Mahoney; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

7.  Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation.

Authors:  D W Morel; P E DiCorleto; G M Chisolm
Journal:  Arteriosclerosis       Date:  1984 Jul-Aug

8.  Protection of low density lipoprotein oxidation by the antioxidant agent IRFI005, a new synthetic hydrophilic vitamin E analogue.

Authors:  L Iuliano; J Z Pedersen; C Camastra; V Bello; S Ceccarelli; F Violi
Journal:  Free Radic Biol Med       Date:  1999-04       Impact factor: 7.376

9.  Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages.

Authors:  A M Fogelman; I Shechter; J Seager; M Hokom; J S Child; P A Edwards
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

Review 10.  Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics.

Authors:  J A Berliner; M Navab; A M Fogelman; J S Frank; L L Demer; P A Edwards; A D Watson; A J Lusis
Journal:  Circulation       Date:  1995-05-01       Impact factor: 29.690

View more
  12 in total

Review 1.  Furan fatty acids: occurrence, synthesis, and reactions. Are furan fatty acids responsible for the cardioprotective effects of a fish diet?

Authors:  Gerhard Spiteller
Journal:  Lipids       Date:  2005-08       Impact factor: 1.880

2.  Oxidized LDL stimulates lipid peroxidation-derived DNA and protein adducts in human vascular endothelial and smooth muscle cells.

Authors:  Shuang Liu; Wei Hou; Hua Qin; Ying Wang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-04-16

Review 3.  The mitochondrial paradigm for cardiovascular disease susceptibility and cellular function: a complementary concept to Mendelian genetics.

Authors:  David M Krzywanski; Douglas R Moellering; Jessica L Fetterman; Kimberly J Dunham-Snary; Melissa J Sammy; Scott W Ballinger
Journal:  Lab Invest       Date:  2011-06-06       Impact factor: 5.662

4.  Overexpression of peroxiredoxin 4 attenuates atherosclerosis in apolipoprotein E knockout mice.

Authors:  Xin Guo; Sohsuke Yamada; Akihide Tanimoto; Yan Ding; Ke-Yong Wang; Shohei Shimajiri; Yoshitaka Murata; Satoshi Kimura; Takashi Tasaki; Atsunori Nabeshima; Teruo Watanabe; Kimitoshi Kohno; Yasuyuki Sasaguri
Journal:  Antioxid Redox Signal       Date:  2012-06-12       Impact factor: 8.401

5.  Homocysteine accumulates in supernatants of stimulated human peripheral blood mononuclear cells.

Authors:  K Schroecksnadel; B Frick; B Wirleitner; H Schennach; D Fuchs
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

6.  Effects of GW274150, a novel and selective inhibitor of iNOS activity, in acute lung inflammation.

Authors:  Laura Dugo; Stefania Marzocco; Emanuela Mazzon; Rosanna Di Paola; Tiziana Genovese; Achille P Caputi; Salvatore Cuzzocrea
Journal:  Br J Pharmacol       Date:  2004-02-09       Impact factor: 8.739

Review 7.  The role of tobacco smoke induced mitochondrial damage in vascular dysfunction and atherosclerosis.

Authors:  Zhen Yang; Corey M Harrison; Gin C Chuang; Scott W Ballinger
Journal:  Mutat Res       Date:  2007-03-01       Impact factor: 2.433

8.  Inhibition or knock out of inducible nitric oxide synthase result in resistance to bleomycin-induced lung injury.

Authors:  Tiziana Genovese; Salvatore Cuzzocrea; Rosanna Di Paola; Marco Failla; Emanuela Mazzon; Maria Angela Sortino; Giuseppina Frasca; Elisa Gili; Nunzio Crimi; Achille P Caputi; Carlo Vancheri
Journal:  Respir Res       Date:  2005-06-14

9.  The associations of uric acid, cardiovascular and all-cause mortality in peritoneal dialysis patients.

Authors:  Jie Dong; Qing-Feng Han; Tong-Ying Zhu; Ye-Ping Ren; Jiang-Hua Chen; Hui-Ping Zhao; Meng-Hua Chen; Rong Xu; Yue Wang; Chuan-Ming Hao; Rui Zhang; Xiao-Hui Zhang; Mei Wang; Na Tian; Hai-Yan Wang
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

10.  Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells.

Authors:  Elizabeth A DiBlasio-Smith; Maya Arai; Elaine M Quinet; Mark J Evans; Tad Kornaga; Michael D Basso; Liang Chen; Irene Feingold; Anita R Halpern; Qiang-Yuan Liu; Ponnal Nambi; Dawn Savio; Shuguang Wang; William M Mounts; Jennifer A Isler; Anna M Slager; Michael E Burczynski; Andrew J Dorner; Edward R LaVallie
Journal:  J Transl Med       Date:  2008-10-16       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.